Results 101 to 110 of about 229,057 (243)
Mixed autoimmune hemolytic anemia (AIHA) is a rare condition characterized by the presence of both warm and cold autoantibodies, often leading to severe, treatment‐resistant hemolysis. In this systematic review of 81 patients across 35 studies, the median age was 45 years with a notable female predominance.
Jeremy W. Jacobs+12 more
wiley +1 more source
Profound Thrombocytopenia and Dyspnea 11 Days After Cardiac Surgery
American Journal of Hematology, EarlyView.
Sebastian Vuong+3 more
wiley +1 more source
ABSTRACT We analyzed 193 Fanconi anemia patients from the Italian Registry, focusing on hematological outcome, cancer risk, and mortality, both in transplanted (n = 130, 67.4% of the cohort) and non‐transplanted (n = 63, 36.6% of the cohort) patients. After a median follow‐up of 7 years, almost all patients developed cytopenia that was more frequent in
Erica Ricci+35 more
wiley +1 more source
Thrombocytopenia and Anemia After Cardiac Surgery
American Journal of Hematology, EarlyView.
Myriam Beshai+2 more
wiley +1 more source
ABSTRACT The coronavirus disease 2019 (COVID‐19) pandemic created major challenges for allogeneic hematopoietic stem cell transplantation (allo‐HSCT). Scientific societies and authorities recommended cryopreserving grafts before starting conditioning regimens, despite limited data on the clinical impact.
Irene Defrancesco+52 more
wiley +1 more source
ABSTRACT Background Residential proximity to commercial pesticide application has been associated with increased odds of developing chronic rhinosinusitis (CRS) with in vitro studies demonstrating cytotoxic dose‐dependent effects on sinonasal epithelia.
Melodyanne Y. Cheng+8 more
wiley +1 more source
A cross-sectional study on the endorsement of reporting guidelines and clinical trial registration among immunology and allergy journals. [PDF]
Khan A+7 more
europepmc +1 more source
Transformative potential of GPT-4o in clinical immunology and allergy: Opportunities and challenges of real-time voice interaction. [PDF]
Li Q, Li PH.
europepmc +1 more source
Elexacaftor–Tezacaftor–Ivacaftor Improves Sinonasal Outcomes in Young Children With Cystic Fibrosis
ABSTRACT Background Severe chronic rhinosinusitis (CRS) is a near universal manifestation of cystic fibrosis. Elexacaftor/tezacaftor/ivacaftor (ETI) is an oral, small molecule, highly effective Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) corrector–potentiator drug.
Amanda L. Stapleton+10 more
wiley +1 more source